Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad W Euler

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Antibiotics (Basel, Switzerland)|February 15, 2020
Gram-Negative Bacterial LysinsChandrabali Ghose, Chad W Euler
Frontiers in Microbiology|April 4, 2022
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin InfectionsRyan D Heselpoth, Chad W Euler, Vincent A Fischetti
Antimicrobial Agents and Chemotherapy|November 12, 2025
Second-generation lysocins as therapeutics for treating <i>Pseudomonas aeruginosa</i> infectionsRyan D Heselpoth, Chad W Euler, Vincent A Fischetti
Antimicrobial Agents and Chemotherapy|September 23, 2015
Using a Novel Lysin To Help Control Clostridium difficile InfectionsQiong Wang, Chad W Euler, Aurelia Delaune, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative BacteriaRyan D Heselpoth, Chad W Euler, Raymond Schuch, et al.
Annals of the New York Academy of Sciences|May 3, 2003
Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr miceMark J Shlomchik, Chad W Euler, Sean C Christensen, et al.
Plos Pathogens|January 12, 2018
Strains of bacterial species induce a greatly varied acute adaptive immune response: The contribution of the accessory genomeUri Sela, Chad W Euler, Joel Correa da Rosa, et al.
Cell Host & Microbe|February 26, 2025
Bacteria exploit viral dormancy to establish CRISPR-Cas immunityNicholas C Keith, Rhett A Snyder, Chad W Euler, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremiaRolf Lood, Assaf Raz, Henrik Molina, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureusDaniel B Gilmer, Jonathan E Schmitz, Chad W Euler, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Antibiotics (Basel, Switzerland)|February 15, 2020
Gram-Negative Bacterial LysinsChandrabali Ghose, Chad W Euler
Frontiers in Microbiology|April 4, 2022
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin InfectionsRyan D Heselpoth, Chad W Euler, Vincent A Fischetti
Antimicrobial Agents and Chemotherapy|November 12, 2025
Second-generation lysocins as therapeutics for treating <i>Pseudomonas aeruginosa</i> infectionsRyan D Heselpoth, Chad W Euler, Vincent A Fischetti
Antimicrobial Agents and Chemotherapy|September 23, 2015
Using a Novel Lysin To Help Control Clostridium difficile InfectionsQiong Wang, Chad W Euler, Aurelia Delaune, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative BacteriaRyan D Heselpoth, Chad W Euler, Raymond Schuch, et al.
Annals of the New York Academy of Sciences|May 3, 2003
Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr miceMark J Shlomchik, Chad W Euler, Sean C Christensen, et al.
Plos Pathogens|January 12, 2018
Strains of bacterial species induce a greatly varied acute adaptive immune response: The contribution of the accessory genomeUri Sela, Chad W Euler, Joel Correa da Rosa, et al.
Cell Host & Microbe|February 26, 2025
Bacteria exploit viral dormancy to establish CRISPR-Cas immunityNicholas C Keith, Rhett A Snyder, Chad W Euler, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremiaRolf Lood, Assaf Raz, Henrik Molina, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureusDaniel B Gilmer, Jonathan E Schmitz, Chad W Euler, et al.
Pageof 3